Quick Recognition of Aortic Dissection
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT05699395 |
Recruitment Status :
Recruiting
First Posted : January 26, 2023
Last Update Posted : January 26, 2023
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment |
---|---|
Aortic Dissection | Diagnostic Test: Non interventional |
Study Type : | Observational |
Estimated Enrollment : | 600 participants |
Observational Model: | Cohort |
Time Perspective: | Prospective |
Official Title: | Identification of Aortic Dissection Based on Pulse Oxygen and Ultrasound Doppler Waveforms |
Actual Study Start Date : | December 1, 2022 |
Estimated Primary Completion Date : | December 31, 2024 |
Estimated Study Completion Date : | May 31, 2025 |
Group/Cohort | Intervention/treatment |
---|---|
Aortic Dissection |
Diagnostic Test: Non interventional
No intervention |
Non Aortic Dissection |
Diagnostic Test: Non interventional
No intervention |
- Diagnosis of aortic dissection [ Time Frame: First 24-hours during emergency dapartment stay ]aortic dissection confirmed by CTA

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 90 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- High risk chest pain with CTA
Exclusion Criteria:
- shock
- coma
- severe peripheral vascular diseases

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05699395
China | |
Zhongshan Hospital, Fudan University | Recruiting |
Shanghai, China | |
Contact: Jingchao Luo, MD 13121021484 sucapter@163.com |
Responsible Party: | Shanghai Zhongshan Hospital |
ClinicalTrials.gov Identifier: | NCT05699395 |
Other Study ID Numbers: |
QRAD2022 |
First Posted: | January 26, 2023 Key Record Dates |
Last Update Posted: | January 26, 2023 |
Last Verified: | November 2022 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Aneurysm, Dissecting Aneurysm Vascular Diseases Cardiovascular Diseases |